Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic-United States, January 2019-September 2020.

ABSTRACT:

Objective

We describe changes in commercial insurance claims for contraceptive services during the beginning of the COVID-19 pandemic.

Methods

We analyzed commercial insurance claims using IQVIA PharMetrics Plus data from more than 9 million U.S. females aged 15-49 years, enrolled during any month, January 2019 through September 2020. We calculated monthly rates of outpatient claims for intrauterine devices (IUDs), implants, and injectable contraception and monthly rates of pharmacy claims for contraceptive pills, patches, and rings. We used Joinpoint regression analysis to identify when statistically significant changes occurred in trends of monthly claims rates for each contraceptive method. We calculated monthly percentages of claims for contraceptive counseling via teleh

SUBMITTER: Curtis KM 

PROVIDER: S-EPMC11283820 | biostudies-literature | 2024 Mar-Apr

REPOSITORIES: biostudies-literature